SCHEMBL7096847

SCHEMBL7096847

CCCN(Cc1cccc(-c2noc(C)n2)c1)C(=O)Nc1ccc(-c2ccccc2SC)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.40
TP53 P04637 4/20 0.40
POLB P06746 2/20 0.40
LMNA P02545 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 2/20 0.39
HTT P42858 2/20 0.39
HPGD P15428 2/20 0.39
ROCK2 O75116 2/20 0.39
ROCK1 Q13464 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 1/20 0.39
CDC42BPA Q5VT25 1/20 0.39
HTR1D P28221 2/20 0.38
HTR1B P28222 2/20 0.38
HTR2A P28223 2/20 0.38
MAPK1 P28482 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7098174 0.87 LMNA (0.42) MAPTTP53POLBLMNASMN1; SMN2
SCHEMBL7072131 0.87 LTB4R2 (0.43) MAPTTP53POLBLMNAALDH1A1
SCHEMBL7084908 0.86 ABHD6 (0.39) TP53LMNASMN1; SMN2HTTCYP2C9
SCHEMBL7097848 0.86 MAPT (0.41) MAPTTP53POLBLMNASMN1; SMN2
SCHEMBL7097252 0.85 MAPT (0.45) MAPTTP53POLBLMNASMN1; SMN2
SCHEMBL7098737 0.84 LMNA (0.40) MAPTTP53POLBLMNASMN1; SMN2
SCHEMBL7098768 0.77 ALDH1A1 (0.46) POLBALDH1A1
SCHEMBL7084912 0.75 TP53 (0.39) MAPTTP53SMN1; SMN2ALDH1A1HPGD
SCHEMBL7094641 0.74 F10 (0.39)
SCHEMBL7087198 0.74 RAB9A (0.42) MAPTTP53POLBLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030171579-A1 Urethane derivatives MERCK PATENT GMBH (DE) 2003-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171579-A1 Urethane derivatives UTS2R, PLAUR, IL1A MAPT 4210/4885TP53 4080/4885POLB 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.